Effective treatment with recombinant factor VIIa of severe bleeding due to acquired factor VIII inhibitor and acquired thrombocytopathy.
Conesa
Venancio
V
Mompel
Angela
A
Lopez
Francisco
F
Marín
Francisca
F
Ruiz
Jose
J
Navarro
Francisco
F
Gomez
Amparo
A
D000368:Aged; D005167:Factor VII / Q000008:administration & dosage*; D015942:Factor VIIa; D017809:Fatal Outcome; D006395:Hemarthrosis / Q000188:drug therapy / Q000209:etiology; D019337:Hematologic Neoplasms / Q000150:complications; D006406:Hematoma / Q000188:drug therapy / Q000209:etiology; D006467:Hemophilia A / Q000188:drug therapy / Q000209:etiology*; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000008:administration & dosage*; D016896:Treatment Outcome
D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa